{"id":7384,"date":"2021-12-16T07:57:33","date_gmt":"2021-12-16T12:57:33","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/bivalirudiini-cas-128270-60-0-on-laboratoriotutkimukseen-tarkoitettu-antikoagulantti\/"},"modified":"2021-12-16T07:57:33","modified_gmt":"2021-12-16T12:57:33","slug":"bivalirudiini-cas-128270-60-0-on-laboratoriotutkimukseen-tarkoitettu-antikoagulantti","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fi\/product\/bivalirudiini-cas-128270-60-0-on-laboratoriotutkimukseen-tarkoitettu-antikoagulantti\/","title":{"rendered":"Bivalirudiini CAS 128270-60-0 on laboratoriotutkimukseen tarkoitettu antikoagulantti"},"content":{"rendered":"

Bivalirudiini CAS 128270-60-0 on laboratoriotutkimukseen tarkoitettu antikoagulantti<\/strong><\/h2>\n

Tuotteen nimi: Bivalirudiini
\nSynonyymit: Bivalirudiini, TFA;BIVALIRUDIN;BIVALIRUDIN TRIFLUOROACETATE;BITTERMELONP.E;Ihmisen bivalirudiini; DPHE-PRO-ARG-PRO-GLY-GLY-GLY-GLY-ASN-GLY-ASP PHE-GLU-GLU-LLE-PRO-GLU-GLU-TYR-LEU; Bivalirudiiniasetaatti; Bivalirudiini BG 8967, Hirulog, Hirulog I
\nCAS: 128270-60-0
\nMF: C98H138N24O33
\n 2180.29
\nEINECS: 274-570-6
\nTuoteluokat: API;proteiinit;peptidi
\nMol Tiedosto: 128270-60-0.mol<\/p>\n

Bivalirudiini on er\u00e4\u00e4nlainen synteettinen uusi antikoagulantti. Se on suora, spesifinen ja palautuva trombiinin est\u00e4j\u00e4. Sen kehitti alun perin Swiss Basset (Biogen). Sitten se siirrettiin United States Medicines Companylle, ja se hyv\u00e4ksyttiin markkinointiin Yhdysvalloissa vuonna 2000. Sen antikoagulanttiainesosa on er\u00e4\u00e4nlainen 20 peptidi\u00e4, jotka on johdettu hirudiinista. Bivalirudiini voi sitoutua spesifisesti katalyyttisen kohdan ja anionin sitoutumiskohdan kanssa riippumatta siit\u00e4, onko trombiinissa oleva trombiini tai veritulppaan sitoutunut trombiini, mik\u00e4 est\u00e4\u00e4 suoraan trombiinin aktiivisuutta. Ja sen roolille on ominaista lyhyt, palautuva. Varhaiset kliiniset tutkimukset osoittavat, ett\u00e4 bivalirudiinin antikoagulaatiohoito on hyv\u00e4. Ja verenvuototapahtumien ilmaantuvuus on alhainen. Joten sen k\u00e4ytt\u00f6 on turvallisempaa kuin perinteinen hepariinihoito. Sit\u00e4 k\u00e4ytet\u00e4\u00e4n p\u00e4\u00e4asiassa est\u00e4m\u00e4\u00e4n angioplastian interventiohoito ep\u00e4stabiilin angina pectoriksen iskeemisten komplikaatioiden hoidossa ennen ja j\u00e4lkeen.<\/p>\n

Bivalirudiini CAS 128270-60-0 Kemialliset ominaisuudet<\/strong>
\ntiheys 1,52\u00b10,1 g\/cm3 (ennustettu)
\ns\u00e4ilytysl\u00e4mp\u00f6tila -20\u00b0C
\nmuotojauhe
\nv\u00e4ri valkoisesta luonnonvalkoiseen
\nInChIKey OIRCOABEOLEUMC-GEJPAHFPSA-N<\/p>\n

Bivalirudiinin k\u00e4ytt\u00f6tarkoitukset CAS 128270-60-0<\/strong>
\nAntikoagulantti; antitromboottinen.<\/p>\n

Biluvudiini on synteettinen antikoagulantti, hirudiinin 20 peptidin analogi, joka hyv\u00e4ksyttiin markkinoille Yhdysvalloissa vuonna 2000. Bivalirudiini sitoutuu spesifisesti trombiinin katalyyttiseen kohtaan ja anioniseen ulkoiseen sitoutumiskohtaan , inhiboi suoraan trombiinin aktiivisuutta ja est\u00e4\u00e4 siten trombiinin katalysoimia ja indusoimia reaktioita, ja sen vaikutus on palautuva. Bivalirudiinia k\u00e4ytet\u00e4\u00e4n p\u00e4\u00e4asiassa antikoagulanttina elektiiviseen perkutaaniseen sepelvaltimointerventioon (PCI) aikuisilla.<\/p>\n","protected":false},"excerpt":{"rendered":"

Tuotteen nimi: Bivalirudiini
\nCAS: 128270-60-0
\nMF: C98H138N24O33
\nMW: 2180.29
\nEINECS: 274-570-6
\nMol Tiedosto: 128270-60-0.mol<\/p>\n","protected":false},"featured_media":2268,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[406],"product_tag":[2386],"class_list":{"0":"post-7384","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-veren-ja-verisuonten-peptidi","7":"product_tag-bivalirudin-cas-128270-60-0-is-an-anticoagulant-for-lab-research-fi","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product\/7384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/comments?post=7384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media\/2268"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media?parent=7384"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_brand?post=7384"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_cat?post=7384"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_tag?post=7384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}